The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients: A Pilot Study
Phase 4
Completed
- Conditions
- Cancers, Pain
- Interventions
- Drug: Cancer pain management
- Registration Number
- NCT01043068
- Lead Sponsor
- National Cancer Center, Korea
- Brief Summary
The purpose of this study was to prospectively evaluate the effect of cancer pain management protocol on hospitalized cancer patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
- Hospitalized patient with the somatic and/or visceral pain having an untreated intensity greater than 3 on a 10 cm visual analog scale (VAS; 0 = no pain, 10 = unbearable pain)over the week prior to enrollment
- A minimum age of 18 years
Exclusion Criteria
- Opioid intolerance
- No longer treatment for their underlying disease.
- Intracerebral primary or metastatic lesion
- Impaired sensory or cognitive function
- Pregnant or lactating woman
- Women of child bearing potential not using a contraceptive method
- Sexually active fertile men not using effective birth control during medication of study drug and up to 6 months after completion of study drug if their partners are women of child-bearing potential
- Any patients judged by the investigator to be unfit to participate in the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Pain control Cancer pain management Interventions based on published pain guideline. The interventions consisted of the following: (1) nursing pain assessment of current pain, worst pain, pain relief, and acceptability of pain; (2) feedback to guide analgesic prescribing by physician.
- Primary Outcome Measures
Name Time Method Reduction in pain scores Jan 2010 - October 2010
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
National Cancer Center
🇰🇷Goyang, Gyeonggi-do, Korea, Republic of